IOL CHEMICALS & PHARM. | CORAL LAB. | IOL CHEMICALS & PHARM./ CORAL LAB. |
|||
---|---|---|---|---|---|
P/E (TTM) | x | 13.6 | 14.8 | 92.3% | View Chart |
P/BV | x | 1.6 | 0.9 | 178.4% | View Chart |
Dividend Yield | % | 1.0 | 0.0 | - |
IOL CHEMICALS & PHARM. CORAL LAB. |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
IOL CHEMICALS & PHARM. Mar-23 |
CORAL LAB. Mar-23 |
IOL CHEMICALS & PHARM./ CORAL LAB. |
5-Yr Chart Click to enlarge
|
||
High | Rs | 537 | 368 | 145.8% | |
Low | Rs | 272 | 217 | 125.4% | |
Sales per share (Unadj.) | Rs | 377.6 | 218.8 | 172.6% | |
Earnings per share (Unadj.) | Rs | 23.7 | 18.1 | 131.3% | |
Cash flow per share (Unadj.) | Rs | 31.6 | 24.2 | 130.6% | |
Dividends per share (Unadj.) | Rs | 4.00 | 0 | - | |
Avg Dividend yield | % | 1.0 | 0 | - | |
Book value per share (Unadj.) | Rs | 256.8 | 433.6 | 59.2% | |
Shares outstanding (eoy) | m | 58.71 | 3.57 | 1,644.5% | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 1.1 | 1.3 | 80.1% | |
Avg P/E ratio | x | 17.1 | 16.2 | 105.3% | |
P/CF ratio (eoy) | x | 12.8 | 12.1 | 105.8% | |
Price / Book Value ratio | x | 1.6 | 0.7 | 233.3% | |
Dividend payout | % | 16.9 | 0 | - | |
Avg Mkt Cap | Rs m | 23,743 | 1,045 | 2,272.1% | |
No. of employees | `000 | NA | NA | - | |
Total wages/salary | Rs m | 1,682 | 111 | 1,510.8% | |
Avg. sales/employee | Rs Th | 0 | 0 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 0 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 22,171 | 781 | 2,838.1% | |
Other income | Rs m | 256 | 69 | 371.4% | |
Total revenues | Rs m | 22,427 | 850 | 2,638.1% | |
Gross profit | Rs m | 2,257 | 39 | 5,861.6% | |
Depreciation | Rs m | 462 | 22 | 2,117.4% | |
Interest | Rs m | 165 | 3 | 4,858.4% | |
Profit before tax | Rs m | 1,887 | 82 | 2,293.3% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 495 | 18 | 2,779.9% | |
Profit after tax | Rs m | 1,391 | 64 | 2,158.9% | |
Gross profit margin | % | 10.2 | 4.9 | 206.5% | |
Effective tax rate | % | 26.2 | 21.6 | 121.2% | |
Net profit margin | % | 6.3 | 8.3 | 76.1% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 9,667 | 1,235 | 782.5% | |
Current liabilities | Rs m | 5,025 | 119 | 4,237.1% | |
Net working cap to sales | % | 20.9 | 143.0 | 14.6% | |
Current ratio | x | 1.9 | 10.4 | 18.5% | |
Inventory Days | Days | 43 | 231 | 18.7% | |
Debtors Days | Days | 8 | 1,094 | 0.8% | |
Net fixed assets | Rs m | 11,017 | 508 | 2,168.6% | |
Share capital | Rs m | 587 | 36 | 1,643.2% | |
"Free" reserves | Rs m | 14,490 | 1,512 | 958.2% | |
Net worth | Rs m | 15,077 | 1,548 | 974.0% | |
Long term debt | Rs m | 0 | 0 | - | |
Total assets | Rs m | 20,684 | 1,743 | 1,186.4% | |
Interest coverage | x | 12.5 | 25.3 | 49.3% | |
Debt to equity ratio | x | 0 | 0 | - | |
Sales to assets ratio | x | 1.1 | 0.4 | 239.2% | |
Return on assets | % | 7.5 | 3.9 | 193.3% | |
Return on equity | % | 9.2 | 4.2 | 221.6% | |
Return on capital | % | 13.6 | 5.5 | 245.9% | |
Exports to sales | % | 26.7 | 92.1 | 29.1% | |
Imports to sales | % | 0 | 0 | - | |
Exports (fob) | Rs m | 5,930 | 719 | 824.5% | |
Imports (cif) | Rs m | NA | NA | - | |
Fx inflow | Rs m | 5,930 | 719 | 824.5% | |
Fx outflow | Rs m | 6,052 | 13 | 45,399.8% | |
Net fx | Rs m | -122 | 706 | -17.2% |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 1,223 | 127 | 965.4% | |
From Investments | Rs m | -1,200 | -26 | 4,588.9% | |
From Financial Activity | Rs m | -41 | -64 | 64.0% | |
Net Cashflow | Rs m | -18 | 36 | -50.8% |
Indian Promoters | % | 48.2 | 20.0 | 241.3% | |
Foreign collaborators | % | 0.0 | 51.5 | - | |
Indian inst/Mut Fund | % | 1.7 | 0.1 | 1,214.3% | |
FIIs | % | 1.4 | 0.1 | 1,000.0% | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 51.8 | 28.5 | 181.9% | |
Shareholders | 130,003 | 4,098 | 3,172.4% | ||
Pledged promoter(s) holding | % | 0.0 | 0.0 | - |
Compare IOL CHEMICALS & PHARM. With: DIVIS LABORATORIES CIPLA SUN PHARMA ZYDUS LIFESCIENCES DR. REDDYS LAB
No comparison is complete without understanding how the stock prices have performed over a period of time.
Here's a brief comparison:
Period | IOL CHEMICALS & PHARM. | CORAL LAB. | S&P BSE HEALTHCARE |
---|---|---|---|
1-Day | -0.08% | -1.81% | 0.45% |
1-Month | 5.56% | -2.60% | 2.55% |
1-Year | -2.82% | 46.21% | 56.14% |
3-Year CAGR | -12.94% | -3.93% | 15.22% |
5-Year CAGR | 16.77% | 2.55% | 19.63% |
* Compound Annual Growth Rate
Here are more details on the IOL CHEMICALS & PHARM. share price and the CORAL LAB. share price.
Moving on to shareholding structures...
The promoters of IOL CHEMICALS & PHARM. hold a 48.2% stake in the company. In case of CORAL LAB. the stake stands at 71.5%.
To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of IOL CHEMICALS & PHARM. and the shareholding pattern of CORAL LAB..
Finally, a word on dividends...
In the most recent financial year, IOL CHEMICALS & PHARM. paid a dividend of Rs 4.0 per share. This amounted to a Dividend Payout ratio of 16.9%.
CORAL LAB. paid Rs 0.0, and its dividend payout ratio stood at 0.0%.
You may visit here to review the dividend history of IOL CHEMICALS & PHARM., and the dividend history of CORAL LAB..
For a sector overview, read our pharmaceuticals sector report.
After opening the day on high, Indian share markets reversed the trend as the session progressed and ended the lower.